Bill of Health

NOVEMBER 29, 2023

Johnson & Johnson’s ketamine-based formulation generated $183 million in Q3, surpassing Pfizer’s erectile dysfunction (ED) drug, which earned $110 million over the same period. Viagra: The Pharmaceutical Circle of Life In the 1990s, Pfizer was struggling to develop one of their compounds, sildenafil , for high blood pressure.

FDA 260

FDA Pharmaceutical Industry Licensing 260

Dot Compliance

APRIL 14, 2023

They are already revolutionizing how companies develop, manufacture and deliver products into the hands of clinicians and patients. Today, 45% of life sciences companies’ technology investments are made in three analytics-related technologies – applied AI, industrialized machine learning (ML), and cloud and edge computing.

FDA 52

FDA Compliance 52

Dot Compliance

FEBRUARY 23, 2024

Companies that adopt a strategic approach to AI, focusing on practical and proven applications, where AI informs decision-makers rather than making decisions, can expedite time to value. Generative AI: Generative AI has gained attention since the launch of ChatGPT, prompting companies in various industries to explore its potential value.

FDA 52

FDA Regulatory Compliance Compliance 52

Drug & Device Law

JULY 31, 2023

More recently, Johnson v. Medicis Pharmaceutical Corp. , which] implies that the manufacturer of a good is the person or company who brings the good into its tangible form − the point at which the good is ready for sale, or resale, to the consuming public. vs. Ortho-McNeil-Janssen Pharmaceuticals , 2013 WL 2917651 (Pa.

Governance 52

Governance Payment Systems Hospitals Licensing 52

Drug & Device Law

FEBRUARY 25, 2022

We continue to believe that PLAC membership helps pharmaceutical and medical device defendants litigate stronger (through inter-industry cooperation on shared issues of concern), smarter (through cutting edge CLE and webinars), and more efficiently (utilizing PLAC’s online knowledge base and other resources). Janssen Pharmaceuticals, Inc.

FDA 59

FDA 59

Drug & Device Law

AUGUST 31, 2023

She asserted negligence, design-defect, failure-to-warn, and manufacturing-defect claims against the manufacturer and its holding company. The court dismissed all claims aginst the holding company for lack of personal jurisdiction. Ortho-McNeil-Janssen Pharmaceuticals, Inc. , Johnson & Johnson , 947 F.3d

FDA 59

FDA 59